Hepatitis C is a contagious liver disease that's caused ... But others may need treatment. Now, new treatments called Direct Antiviral Agents -- or DAAs -- are available that are safer, faster ...

The publication of the WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection coincides with a wave of new oral treatments for hepatitis, which promise to be ...

Hepatitis C drug Ganovo won a top clinical research ... Non-cirrhotic patients on a treatment regimen of Ganovo, which is produced by Chinese biotech company, Ascletis, demonstrated a cure rate ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

The UK Health Security Agency (UKHSA) has announced the launch of a whole genome sequencing service to tackle hepatitis C virus (HCV). The service is aimed at monitoring drug resistance, detecting ...

The data on hepatitis in the WHO Global Health Report 2024 is based on modelling and not actual surveillance, the Rajya Sabha ...